Precigen
PGEN
#5472
Rank
โ‚น116.16 B
Marketcap
โ‚น328.31
Share price
-0.95%
Change (1 day)
384.71%
Change (1 year)

Revenue for Precigen (PGEN)

Revenue in 2025 (TTM): โ‚น0.36 Billion

According to Precigen's latest financial reports the company's current revenue (TTM ) is โ‚น0.38 Billion. In 2024 the company made a revenue of โ‚น0.33 Billion a decrease over the revenue in the year 2023 that were of โ‚น0.51 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Precigen from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น0.36 B9.87%
2024 โ‚น0.33 B-35.03%
2023 โ‚น0.51 B-76.73%
2022 โ‚น2.22 B-46.46%
2021 โ‚น4.15 B-44.88%
2020 โ‚น7.54 B28.92%
2019 โ‚น5.85 B-47.87%
2018 โ‚น11.22 B-23.95%
2017 โ‚น14.76 B13.79%
2016 โ‚น12.97 B12.46%
2015 โ‚น11.53 B153.07%
2014 โ‚น4.55 B214.18%
2013 โ‚น1.45 B90.31%
2012 โ‚น0.76 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
โ‚น57.69 B 14,698.82% Jersey
Novavax
NVAX
โ‚น92.00 B 23,502.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
โ‚น12.93 M-96.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚น1.96 B 403.20%๐Ÿ‡ฌ๐Ÿ‡ง UK